Among breast cancers without human epidermal growth factor receptor 2 (HER2) amplification, overexpression, or both, a large proportion express low levels of HER2 that may be targetable. Currently available HER2-directed therapies have been ineffective in patients with these "HER2-low" cancers.
非而者厚
高大凌寒
斯寜
VDC
小海
陈炫铭
若雨凌风
Xiaoxiao
xixi
back you up
CNS冲
小白
jyy
paganina
pluto
Leung
失眠天亦
竹筏过海
zho
冰魂
皖公网安备34019202002308
